论文部分内容阅读
目的分析氨溴索治疗轻中度早产儿呼吸窘迫综合征的疗效。方法随机选取60例轻中度早产儿RDS,分为观察组及对照组,采用氨溴索与基础性方式治疗,对比两组治疗后患儿血气分析情况、呼吸困难缓解情况、整体疗效以及毒副反应情况。结果观察组患儿治疗后血气情况与呼吸情况改善均更明显;观察组总有效率76.7%,对照组为66.7%;观察组整体情况更显著(P<0.05)。结论氨溴索治疗轻中度早产儿呼吸窘迫综合征有一定疗效,值得推广应用。
Objective To analyze the efficacy of ambroxol in the treatment of respiratory distress syndrome in mild to moderate preterm infants. Methods Sixty preterm infants with mild to moderate preterm infants were randomly divided into observation group and control group. Ambroxol and the basic treatment were used. The blood gas analysis, the relief of dyspnea, the overall curative effect and the toxicity were compared between the two groups Side effects. Results The improvement of blood gas and respiration in the observation group was more obvious. The total effective rate was 76.7% in the observation group and 66.7% in the control group. The overall observation group was more significant (P <0.05). Conclusions Ambroxol can treat respiratory distress syndrome in mild to moderate preterm infants with certain curative effect, which is worth popularizing and applying.